Managing chronic nonmalignant pain with continuous intrathecal morphine

Area of Science:

• Pain Management
• Neurology
• Pharmacology

Background:

• Chronic nonmalignant pain affects millions, necessitating effective long-term treatment options.
• Traditional pain management strategies often have limited efficacy and significant side effects.
• Continuous intrathecal morphine via implanted pumps is an alternative, but its long-term outcomes require further investigation.

Purpose of the Study:

• To evaluate the efficacy and safety of continuous intrathecal morphine for chronic nonmalignant pain over one year.
• To assess changes in pain levels, morphine dosage, and complications.
• To explore the impact on patients' daily living activities.

Main Methods:

• A prospective study involving twelve patients completing one year of continuous intrathecal morphine therapy.
• Pain assessment using the McGill Pain Questionnaire and Verbal Descriptor Scale.
• Monitoring of morphine dosage, adverse events, and functional status.

Main Results:

• Significant pain reduction: 42% on McGill Pain Questionnaire and 41% on Verbal Descriptor Scale (p < .01).
• 35% reduction in perceived pain hardship, with anecdotal improvements in daily activities.
• Minimal long-term adverse effects; implantation complications occurred in 33.3% but were manageable.

Conclusions:

• Continuous intrathecal morphine is effective in reducing pain for selected chronic nonmalignant pain patients.
• The therapy demonstrates a favorable safety profile with manageable complications.
• This treatment can improve quality of life and functional capacity in patients with chronic pain.